Gelofusine® – A colloidal volume replacement fluid based on 4 % modified fluid gelatin

B. Braun SE

Product Keywords

  • Provides a wide range of therapeutic indications
  • Provides a readily controllable volume effect over 3-4 hours
  • Provides an immediate increase in intravascular volume and re-establishes disturbed haemodynamics
  • Is completely degraded, degradation products are rapidly excreted
  • Does not effect blood coagulation
  • Is compatible with blood and blood products
  • Has no dose limit
  • Lowers the risk of hyperchloremic acidosis due to the reduced, more physiological concentration of chloride ions

More Solutions:

Related Solutions:

2Contact Person
3Contact Details